CA2413248C - Vascular device for valve leaflet apposition - Google Patents

Vascular device for valve leaflet apposition Download PDF

Info

Publication number
CA2413248C
CA2413248C CA002413248A CA2413248A CA2413248C CA 2413248 C CA2413248 C CA 2413248C CA 002413248 A CA002413248 A CA 002413248A CA 2413248 A CA2413248 A CA 2413248A CA 2413248 C CA2413248 C CA 2413248C
Authority
CA
Canada
Prior art keywords
vessel
vascular
vascular device
engaging members
expanded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002413248A
Other languages
French (fr)
Other versions
CA2413248A1 (en
Inventor
James F. Mcguckin, Jr.
Richard T. Briganti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rex Medical LP
Original Assignee
Rex Medical LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rex Medical LP filed Critical Rex Medical LP
Publication of CA2413248A1 publication Critical patent/CA2413248A1/en
Application granted granted Critical
Publication of CA2413248C publication Critical patent/CA2413248C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2475Venous valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0644Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • A61F2/2433Deployment by mechanical expansion using balloon catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes

Abstract

The present invention provides an intravascular device which brings the vessel wall adjacent the vein valve radially inwardly to bring valve leaflets into opposition. The present invention, in one aspect provides a vascular device movable from a collapsed insertion position having a first diameter to an expanded position having a second larger diameter. A plurality of vessel engaging members extend outwardly from the device for securely engaging the internal wall of a vessel upon expansion of the device to the second expanded position. The vessel engaging members pull the internal wall of the vessel radially inwardly upon movement of the device from the second expanded position toward a first expanded position having a third diameter greater than the first diameter and smaller than the second diameter.

Description

VASCULAR DEVICE FOR VALVE LEAFLET APPOSITION
BACKGROUNI) Technical Field This application relates to a vascular device and more particularly to a vascular device for approximatinc, vein valve leaflets for treating venous valve insufficiency.
Backeround of Related Art Veins in the body transport blood to the heart and arteries carry blood away from the heart. The veins have one-way valve structures in the form of leaflets disposed annularly along the inside wall of the vein which open to permit blood flow toward the heart and close to prevent back flow. That is, when blood flows through the vein, the pressure forces the valve leaflets apart as they flex in the direction of blood flow and move towards the inside wall of the vessel, creating an opening therebetween for blood floir=. The leaflets, however, do not normally bend in the opposite direction and therefore return to a closed position to prevent blood flow in the opposite, i.e.
retrograde, direction after the pressure is relieved. The leaflet structures, when fiuictionina properly, extend radially inwardly toward one another such that the tips contact each other to block backflow of blood.
In the condition of venous valve insufficiency, the valve leaflets do not funetion properly as they thicken and lose flexibility, resulting in their inability to extend sufficiently radially inwardly to enable their tips to come into sufficient contact with each other to prevent retrograde blood flow. The retrograde blood flow causes the buildup of hydrostatic pressure on the residual valves and the weight of the blood dilates the wall of the vessel. Such retrograde blood flow, comnionly referred to as reflux, leads to swelling and varicose veins, causing great disconifort and pain to the patient. Such retroarade blood flow, if left untreated can also cause venous stasis ulcers of the skin and subcutaneous tissue. There are generally two types of venous valve insufficiency:
primary and secondary. Primary venous valve insufficiency is typically a condition from birth, where the vein is simply too large in relation to the leaflets so that the leaflets cannot come into adequate contact to prevent backflow. More common is secondary venous valve insufficiency which is caused by clots which gel and scar, thereby changing the configiuration of the leaflets, i.e. thickening the leaflets creating a "stub-like"
configuration. Venous valve insufficiency can occur in the superficial venous system, such as the saphenous veins in the leg, or in the deep venous system, such as the femoral and popliteal veins extending along the back of the knee to the groin.
A common method of treatment of venous valve insufficiency is placement of an elastic stocking around the patient's leg to apply external pressure to the vein, forcing the walls radially inwardly to force the leaflets into apposition. Although sometimes successful, the tight stocking is quite uncomfortable, especially in warm weather, as the stocking must be constantly worn to keep the leaflets in apposition. The elastic stocking also affects the patient's physical appearance, thereby potentially having an adverse psychological affect. This physical and/or psychological discomfort sometimes results in the patient remove the stocking, thereby preventing adequate treatment.
Another method of treatment has been developed to avoid the discomfort of the stocking. This method involves major surgery requiring the implantation of a cuff internally of the body, directly around the vein. This surgery requires a large incision, resulting in a long patient recovery time, scarring and carries the risks, e.g. anesthesia, inherent with surgery.
Another invasive method of surgery involves selective repairing of the valve leaflets, referred to as valvuloplasty. In one method, sutures are utilized to bring the free edges of the valve cusp into contact. This procedure is complicated and has the same disadvantages of the major surgery described above.
It would therefore be advantageous to provide a method and device to minimally invasively treat venous valve insufficiency without requiring an outer stocking or internal cuff. Such device would thereby avoid the physical and psychological discomfort of an external stocking as well as avoid the risk, complexity and expense of surgically implanted cuffs. Such device would advantageously be inserted minimally invasively, i.e. intravascularly, and function to effectively bring the valve leaflets into apposition.
SUMMARY
The present invention overcomes the problems and deficiencies of the prior art by ' providing an intravascular device which brings the vessel wall adjacent the vein valve radially inwardly to bring valve leaflets into apposition. The present invention, in one aspect, provides a vascular device movable from a collapsed insertion position having a first diameter to an expanded position having a second larger diameter. A
plurality of vessel engaging members extend outwardly from the device for securely engaging the internal wall of a vessel upon expansion of the device to the second expanded position.
The vessel engaging members pull the internal wall of the vessel radially inwardly upon movement of the device from the second expanded position toward a first expanded position having a third diameter greater than the first diameter and smaller than the second diameter.
The device is preferably composed of shape memory material and the first expanded position preferably substantially corresponds to the memorized position of the device. In one einbodiment, the device is initially movable from the collapsed position to the first expanded position in response to exposure to body temperature and is subsequently movable to the second expanded position by mechanical means or an inflatable balloon positioned within the device. In another embodiment, the device is movable from the collapsed position to the second expanded position by substantial simultaneous exposure to body temperature and expansion by an expandable member.
The vessel engaging members preferably extend from the distal and proximal portions of the device and have sharp ends to limit axial movement of the vessel wall and barbs to limit radial movement of the vessel wall to enhance retention (securement) of the vessel. The vessel engaging members preferably extend substantially parallel to a longitudinal axis of the device in the collapsed position and substantially perpendicular to the longitudinal axis in the extended position.
In one embodiment, in the collapsed position the middle portion of the device includes a plurality of longitudinal strips with a gap between adjacent strips. In this embodiment, the vessel engaging member is formed by a cut in the respective longitudinal strip and the longitudinal strips buckle radially outwardly upon movement of the device to the first expanded position.
In another embodiment of the present invention, the device includes a plurality of longitudinal strips, each terminating at opposing ends in one of the vessel engaging members. A substantially straight slot can be formed in each of the longitudinal strips in the collapsed position of the device, each slot preferably transforming to a substantially diamond shape when the device is moved to the first expanded position.
In another aspect of the present invention, a vascular device is provided comprising a tubular-like member expandable from a collapsed configuration to an expanded configuration and having a plurality of hooks extending from the tubular member at the proximal end and the distal end. The hooks extend substantially parallel to the longitudinal axis in the collapsed position and substantially perpendicular to the longitudinal axis in the extended position. Barbs may be provided adjacent the hooks for limiting radial movement of a vessel wall engaged by the barbs.
In another aspect of the present invention, a vascular device is. provided comprising a tubular-like member expandable from a collapsed configuration to an expanded configuration. A plurality of vessel engaging members with penetrating tips extend from the proximal, distal and intermediate portions. Expansion of the member to the expanded configuration causes the distal and proximal portions to move axially inwardly and the intermediate portion to buckle radially outwardly to enable the vessel engaging members to securely engage the vessel wall.
In another aspect of the present invention, an expandable vascular device is provided comprising a franlework movable from a collapsed configuration for delivery to a target vessel to an expanded configuration for retaining the vessel. The framework is formed by a plurality of longitudinal strips with adjacent longitudinal strips formed by connecting ribs, and each of the longitudinal strips terminating at opposing ends in a vessel wall penetrating member to engage the vessel wall. In this embodiment, a longitudinal slot is preferably formed in each of the longitudinal strips such that the longitudinal slot forms a substantially diamond shaped slot in the expanded configuration of the device. The longitudinal slots are preferably in substantial axial alignment. The connecting ribs can also be in substantial axial alignm.ent.
The present invention also provides a vascular system comprising a balloon catheter having an elongated shaft and an expandable balloon and a vascular device mounted over the expandable balloon and composed of shape memory material and having a collapsed position and a memorized position. The vascular device is expandable to an expanded position to engage the vessel walls and returnable substantially to the memorized position to bring the walls radially inwardly.
In one embodiment the vascular device is expandable first to the memorized condition in response to exposure to body temperature and subsequently expanded to the expanded position by inflation of the balloon. In another embodiment, the vascular device is expandable to the expanded position as the device is substantially simultaneously exposed to body temperature and the balloon is inflated. The vascular device can be connected to the balloon. A pair of looped sutures can be provided to connect the vascular device to the balloon, the sutures separable from the vascular device upon expansion of the balloon to a predetermined size.
The present invention also provides a method for treating venous valve insufficiency comprising:

inserting a delivery device and a vascular device into a target vessel adjacent valve leaflets of the vessel;
deploying the vascular device to an enlarged diameter to securely engage an internal wall of the vessel; and reducing the diameter of the vascular device to move the vessel wall radially inwardly and bring the valve leaflets closer together.
In one embodiment, the method further includes the step of deploying the vascular device to a first expanded diameter prior to deploying the vascular device to the enlarged diameter, wherein the.first expanded diameter is less than the enlarged diameter.
The step of deploying the vascular device to the enlarged diameter can include the step of inflating a balloon positioned within the device. The step of deploying the vascular device to the first expanded diameter preferably comprises the step of exposing the vascular device from a delivery sheath to enable the vascular device to return to a shape memorized configuration in response to being warmed by body temperature. In another embodiment, the step of deploying the vascular device to an enlarged diameter comprises releasing the vascular device from the delivery device to enable it to return to a shape memorized condition and substantially simultaneously inflating a balloon.
The step of deploying the vascular deviceto an enlarged diameter can move a plurality of penetrating tips of vessel engaging members of the vascular device to a position substantially peipendicular at another angle to a longitudinal axis of the vascular device to dngage the internal wall of the vessel.
The present invention also provides a method of approximating vein valve leaflets comprising:
inserting a vascular device of shape memory material in a collapsed configuration intravascularly to a target vessel;
actuating an expandable member to expand the vascular device to a further expanded configuration to enable wall engaging members of the device to retain the internal vessel wall; and contracting the expandable member to allow the vascular device to contract towards it memorized expanded configuration to bring the valve leaflets closer together.
In one embodiment, the method further comprises the step of releasing the vascular device from a delivery sheath to enable it to return to its memorized expanded configuration prior to the step of actuating the expaiidable member. In another embodiment, the device returns to the memorized expanded configuration in response to exposure to body temperature and the step of actuating the expandable member to expand the vascular device occurs substantially simultaneously with exposure of the device to body temperature.
The wall engaging members preferably each have penetrating tips and the step of actuating the expandable member causes the penetrating tips disposed on a proximal portion and a distal portion of the vascular device to secure the internal vessel wall.
In the foregoing methods the delivery device can be inserted to a position upstream (with respect to blood flow) of the valve leaflets to deliver the vascular device upstream of the valve leaflets. Alternatively it can be inserted to a position downstream of the valve leaflets to deliver the vascular device downstream of the valve leaflets. The delivery device can be inserted through the jugular vein or femoral vein into the popliteal vein or the saphenous vein, or directly into these veins.

BRIEF DESCRIPTION OF THE DRAWINGS
Preferred embodiment(s) of the present disclosure are described herein with reference to the drawings wherein:
Figure 1 is a perspective view of a first embodiment of the vascular device of the present invention shown in the expanded configuration;
Figure 2 is a side view of the vascular device of Figure 1 in the expanded configuration;
Figure 3 is another side view of the vascular device in the expanded configuration, rotated 45 degrees with respect to Figure 2;
Figure 4 is a front view of the vascular device of Figure 1 in the expanded configuration;
Figure 5 is a perspective view of the vascular device of Figure 1 shown in the collapsed configuration for delivery within the vessel;
Figure 6 is a side view of the vascular device of Figure 1 in the collapsed configuration;
Figure 7 is another side view of the vascular device in the collapsed configuration, rotated 45 degrees with respect to Figure 6;
Figure 8 is a perspective view of an alternate embodiment of the vascular device of the present invention shown in the expanded configuration;
Figure 9A is a side view of the vascular device of Figure 8 shown in the expanded configuration;
Figure 9B is a side view similar to Figure 9A except showing an alternate embodiment where the vessel engaging members extend at an angle into the vessel wall;
Figure 10 is a perspective view of the vascular device of Figure 8 in the collapsed configuration for delivery within the vessel;
Figure 11 is a side view of the vascular device of Figure 8 in the collapsed configuration;

Figure 12 illustrates one method of insertion of the vascular device of Figure showing the delivery catheter inserted directly into the popliteal vein in an antegrade direction;
Figure 13 illustrates an alternate method of insertion of the vascular device of Figure 1 through the jugular vein for retrograde insertion into the popliteal vein;
Figure 14 illustrates another method of insertion of the vascular device of Figure 1 showing the delivery catheter inserted through the right femoral vein for retrograde access to the popliteal vein;
Figure 15 illustrates yet another method of insertion of the vascular device of Figure 1 showing a contralateral approach wherein the delivery catheter is inserted through the left femoral vein for advancement around the iliac vein for retrograde insertion into the right popliteal vein;
Figure 16 shows a side view of the delivery catheter for the vascular device of Figure 1, with the vessel wall shown in section, illustrating antegrade insertion of the delivery catheter in the popliteal vein;
Figure 17 is a view similar to Figure 16 showing initial withdrawal of the sheath in the direction of the arrow to partially expose the vascular device of Figure 1;
Figure 18 is a view similar to Figure 16 showing the vascular device of Figure expanded within the vessel, upstream (with respect to blood flow) of the valve leaflets, after the sheath has been fully withdrawn;
Figure 19 is a view similar to Figure 16, showing the vascular device of Figure 1 expanded by a balloon so the vessel engaging members penetrate and retain the vessel wall;
Figure 20 is a view similar to Figure 16, after the balloon is deflated and the catheter withdrawn from the vessel, showing the vascular device returned to its original position pulling the vessel wall together and bringing the valve'leaflets into apposition;
Figures 21A-21C are transverse cross-sectional views of the vascular device of Figure 1 showing its interaction with the vessel wall during delivery and placement, wherein Figure 21A corresponds to the initial position of the vascular device in Figure 18 wherein the vessel engaging members have not penetrated the vessel wall (the balloon has been omitted for clarity);
Figure 21B corresponds to the position of the vascular device in Figure 19' wherein the balloon has been inflated to radially expand the device to a second expanded position to enable the vessel engaging members to penetrate the vessel wall; and Figure 21 C corresponds to the position of the vascular device in Figtire 20 wherein the balloon has been deflated and the device returns to the first expanded position bringing the vessel wall radially inwardly;

Figure 22 shows a side view of the delivery device for the vascular device of Figure 1, with the vessel wall shown in section, illustrating as an alternative, retrograde insertion of the delivery device in the popliteal vein;

Figure 23 is a view similar to Figure 22 showing initial withdrawal of the sheath in the direction of the arrow to partially expose the vascular device of Figure 1;
Figure 24 is a view similar to Figure 22 showing the vascular device of Figure expanded within the vessel, upstream of the valve leaflets, after the sheath has been fully withdrawn;

Figure 25 is a view similar to Figure 22, showing the vascular device of Figure 1 expanded by a balloon so the vessel engaging members penetrate and retain the vessel wall;
Figure 26 is a view similar to Figure 22, after the balloon is deflated and the catheter withdrawn from the vessel, showing the vascular device returned to its original position pulling the vessel wall together and bringing the valve leaflets into apposition;
Figure 27 is a side view of an alternative embodiment of the vascular device in the expanded position shown within a vessel (the vessel wall is shown in section);
Figure 28 is a view similar to Figure 27 showing a balloon expanding the vascular device so the hooks penetrate the vessel wall;
Figure 29 is an enlarged view of the hook of the device of Figure 27 embedded in the vessel wall;

Figure 30 shows a side view of the delivery catheter for the vascular device of Figure 1, with the vessel wall shown in section, illustrating as another alternative, antegrade insertion of the delivery catheter in the~ popliteal vein for positioning of the vascular device downstream of the valve leaflets;
Figure 31 is a view similar to Figure 30 showing initial withdrawal of the sheath in the direction of the arrow to partially expose the vascular device of Figure 1;
Figure 32 is a side view of an alternate embodiment of the delivery system of the present invention having a restraint, the view being similar to Figure 23 in showing the vascular device expanded within the vessel, upstream of the valve leaflets, after the sheath has been withdrawn;
Figure 33 is a view similar to Figure 32, showing the vascular device of Figure 1 expanded by a balloon so the vessel engaging members penetrate and retain the vessel wall, and the restraint being severed by expansion of the balloon; and Figure 34 is a transverse cross-sectional view of the vascular device of Figure 1 with the restraint of Figure 32 shown expanded to the memorized position substantially simultaneously with expansion of the balloon.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Referring now in detail to the drawings where like reference numerals identify similar or like components throughout the several views, Figures 1-7 illustrate a first embodiment of the vascular device of the present invention and Figures 8-11 illustrate a second embodiment of the vascular device of the present invention. The devices, designated generally by reference numerals 10 and 100, are expanded to engage the internal wall of the vessel and contracted to pull the vessel walls radially inwardly. By pulling the vessel wall radially inwardly, the valve leaflets within the vessel are pulled closer together to a functional condition.
Figures 1-4 illustrate vascular device 10 of the first embodiment in the expanded configuration and Figures 5-7 illustrate vascular device 10 in the collapsed configuration.
Vascular device 10 is preferably composed of a shape memory material, such as a nickel-titanium alloy commonly known as Nitinol, so that in its memorized configuration it assumes the shape shown in Figure 1. This shape memory material characteristically exhibits rigidity in the austenitic state and more flexibility in the martensitic state. To facilitate passage from the delivery catheter, the shape memory device is maintained in a collapsed configuration inside a delivery sheath as described in more detail below, where it is cooled by a saline solution to maintain the device below its transition temperature.
The cold saline maintains the temperature dependent device in a relatively softer condition ~as it is in the martensitic state within the sheath. This facilitates the exit of device 10 from the sheath as frictional contact between the device and the inner wall of the sheath would otherwise occur if the device was maintained in a rigid, i.e.
austenitic, condition. When the device 10 is released from the sheath to the target site, it is warmed by body temperature, thereby transitioning in response to this change in temperature to an austenitic expanded condition.
Device 10 is preferably formed from a tubular member, preferably by laser cutting. Device 10 includes a proximal portion 12, and intermediate portion 14 and a distal portion 16. In the expanded condition, the device 10 has four substantially diamond shaped cells 17 forming substantially diamond shaped openings 18 at the proximal portion 12 and four substantially diamond shaped cells 15 forming substantially diamond shaped openings 20 at the distal portion 16. The end regions 19 of the cells 18, and the end regions 21 of the cells 20 are bent outwardly from the plane of the remainder of the cell, in a direction away from the longitudinal axis of the vascular device 10. This better enables the vessel engaging members, described below, to engage the vessel walls.
The intermediate portion 14 is formed of four substantially diamond shaped cells forming substantially diamond shaped openings 22 arranged around a 360 degree arc of the cylindrical tubular member 10, with a longitudinal strip 24 extending through to bisect each cell. Thus, four symmetric bisected cells 23 are formed. Each longitudinal strip 24 has a vessel engaging member 28 extending therefrom to engage the vessel wall as will be described below. In the expanded condition, the longitudinal strip 24 buckles radially outwardly, away from the longitudinal axis of the vascular device 10, to enable the center vessel engaging members 28 (described below) to engage and secure the internal vessel wall.
The geometry of the vascular device 10 can also be appreciated with reference to the collapsed configuration of the vascular device 10 shown in Figure 5-7. As shown, the device 10 is in the form of a cylinder with a reduced diameter. Each longitudinal strip 24 has a cutout 27 to form vessel engaging member 28. The longitudinal strip 24 is tapered in width "w" at its opposing ends 29 which connect to the framework. The longitudinal slot 30 on each side of the strip 24 is substantially straight and has enlarged oval-like regions 32 at opposing ends. The outer wall 34 of each longitudinal slot 30, i.e. the wall of slot 34 'spaced further from the longitudinal strip 24, is joined to the outer wall 34 of an adjacent longitudinal slot 30 by transverse rib 36. Each rib 36 forms one vertex of a cell 15 and one vertex of a cell 17 when expanded. The cell openings 18 and 20 in the collapsed configuration as shown in Figure 6, have, respectively, a narrowed elongated portion 20a, 18a, and a widened portion 20b, 18b with flared out regions 20c, 18c, to form the diamond shaped openings having bent end regions 21, 19 when device 10 is expanded. The flared out regions 20c, 18c enable the formation of such bent regions 21, 19.
A vessel engaging member extends from the framework of each of the cells 15 and 17. The vessel engaging member is preferably in the fonn of a hook with a penetrating tip and a barb.
More specifically, a vessel engaging member 40 extends outwardly and distally from the frame of each of the four cells 15 at the distal portion 16 of the device 10. In the collapsed configuration of device 10, each member 40 preferably extends generally parallel to the longitudinal axis of vascular device 10 and in substantially the same plane as the corresponding rib 36 at the opposing end.
Similarly, vessel engaging members 42 extend outwardly and proximally from the framework of each of the four cells 17 at the proximal portion 12 of the device 10. In the collapsed configuration of device 10, each member 42 preferably extends generally parallel to the longitudinal axis of vascular device 10 and in the same plane as the corresponding rib 36 at the opposing end The four vessel engaging members 28 formed in the middle (intermediate) portion 14 in the collapsed configuration lie substantially parallel the longitudinal axis of the device 10 and iri the same plane as the longitudinal strip 24 from which it is formed.
Each of the vessel engaging members 28, 40 and 42, are preferably in the form of a hook having a penetrating tip 29, 41 and 43 to pierce the vessel wall and a barb 31, 45 and 47, respectively, to help retain the vessel wall. The sharp penetrating tips 29, 41, 43 penetrate the vessel wall in a radial direction and hold the vessel against axial movement with respect to the device 10; barbs 31, 45, 47, restrict radial movement of the vessel with respect to the device 10, thereby together securely retaining (grasping) the vessel wall for' radial inward movement described below.
It should be understood that although four vessel engaging members 42, 40, 28 are described extending from the proximal and distal cells 17, 15 and from the center longitudinal strips 24, respectively, a fewer or greater number of vessel engaging members can be provided as long as they achieve the vessel retaining function as described in more detail below.
When the vascular device 10 expands, members 28, 40 and 42 are moved to a shape memorized orientation bent outwardly at an angle, preferably about 90 degrees, with respect to the longitudinal axis "A" of the device 10 with regions 19 and 21 bending out of the plane to increase the distance the members can extend from the center to the vessel wall. Longitudinal strips 24 buckle radially outwardly, and members 28 bend outwardly at an angle, preferably about 90 degrees, with respect to the longitudinal axis, to engage the vessel wall. Although 90 degree angles are shown, clearly other angles are contemplated. Note that due to the geometry of the device 10, the points at the outer edge come inwardly axially, shortening the length of the device, and the center strut (strip) 24 buckles radially outwardly. The buckling extends the radial reach of the device 10. Note also that in the expanded configuration, the tips of the vessel engaging members terminate at substantially the same distance from the longitudinal axis of the device 10. The length of the end hooks is preferably the same as the length of the middle hooks; the bent regions 19, 21 accommodate for the buckling of strut 24. Due to the laser cut configuration, foreshortening, i.e. the reduction in length of the device in response to expansion, is reduced.
By way of example, for use for instance in an unhealthy dilated vessel of 14 mm.
the length of the vascular device 10 in the collapsed configuration could be about 3cm and the outer diameter about 3.5mm. In the memorized expanded configuration, the length decreases to about 2.8cm and the transverse cross-sectional dimension increases to about 12mm, 15.5 mm if the 1.7mm hooks are included. Note that the length change is due mostly to the buckling strip and the bent regions since the amount of foreshortening is minimized. These dimensions are provided by way of example as other dimensions are clearly contemplated by the present invention and use in different size vessels is also contemplated.
An alternate preferred embodiment of the vascular device of the present invention is shown in Figures 8-1 l, with Figures 8 and 9 showing the device in the expanded configuration and Figures 10-11 showing the collapsed configuration for delivery to the vessel.
Turning first to Figures 10 and 11, the device 100 is preferably laser cut from a cylindrical tube, forming a series, e.g. ten, of symmetrical longitudinal strips 102 terminating at opposite ends with vessel engaging members 110, 112. Each strip 102 has a longitudinal slot 104 formed therein having a uniform width throughout its length.
Adjacent strips 102 are joined by transverse ribs or struts 106, creating a gap 108, 109 on either side of the ribs 106 between strips 102. Consequently, the device can be considered as fornZing one centrally located column of slots 104 with ribs 106 in axial alignment and slots 104 in axial alignment.
The vessel engaging members 110 and 112 are preferably in the form of hooks as described above in the first embodiment with each vessel engaging member 110 having a penetrating tip 114 and barb 116 and each member 112 having a penetrating tip 118 and barb 119. The penetrating tips 114 and 118 penetrate the vessel wall and prevent axial movement while the barbs 116, 119 restrict radial movement. In the collapsed configuration, as shown, the vessel engaging members 110, 112 are substantially parallel.
to the longitudinal axis of device 100, lying in the same plane as the respective longitudinal strip 102.
As shown, the cylindrical tubular member is formed into ten longitudinal strips 102 with ten hooks 110 at the proximal end 105 and ten hooks 112 at the distal end 107.
Although ten longitudinal strips and ten vessel engaging members are shown on each end, it should be appreciated that fewer or greater number of longitudinal strips and vessel engaging members can be utilized. Moreover, not all of the longitudinal strips need to terminate in vessel engaging members, provided a sufficient number of strips have vessel engaging members to adequately secure the vessel.

The structure of the vascular device 100 is shown in its first expanded configuration in Figures 8 and 9. Vascular device 100, like device 10, is composed of a shape memory material, such as Nitinol, so that in its memorized configuration it assumes the shape shown in Figure 8. The shape memory device is maintained in a collapsed configuration inside a sheath as described in more detail below, where it is cooled by a saline solution to maintain the device below its transition temperature. VWhen the device 100 is delivered to'the target site and released from the sheath, it is warmed by body temperature, thereby transitioning in response to this change in temperature to an austenitic expanded condition. Maintenance of the device in its softened martensitic state within the sheath facilitates delivery to the vessel as frictional contact between the device 100 and the internal walls of the delivery sheath would otherwise occur if the device was retained within the sheath in its austenitic condition.
When expanded, longitudinal slots 104 form substantially diamond shaped cells 120 with substantially diamond shaped openings 122. Upon expansion, the vessel engaging members 110 and 112 extend at an angle, preferably about 90 degrees, to the longitudinal axis of the vascular device 10 to enable the vessel engaging members 110 and 112 to engage and secure the vessel wall (see e.g. Figure 9A). However, it is also contemplated that the vessel engaging members 110',112' could extend at a different angle, for example about 60 degrees, as shown in the alternative embodiment of Figure 9B.
As the device moves from the collapsed configuration to the expanded configuration, it shortens in axial length as the diameter increases. For example, in one embodiment the length of the vascular device 100 in the collapsed configuration is about 1.8cm and the diameter is about 3.5 mm. In the expanded configuration, the length decreases to about 1 cm, mainly due to the hooks bending up as foreshortening is minimized, and the diameter in the memorized expanded configuration increases to about 12 mm. (15.5.if the 1.75 mm hook length is included). These dimensions are provided by' way of example as other dimensions are clearly contemplated.
Turning to the method of use of the vascular devices of the present invention, the insertion of vascular device 10 will be described, it being understood that vascular device 100 would be inserted in the same manner and expanded and retracted in the same manner as device 10.
There are several different methods of insertion of the vascular device of the present invention for treating venous valve insufficiency of the popliteal or saphenous vein. Figures 12-15 illustrate examples of some of these approaches by illustrating various access vessels for the delivery devices to reach these veins. In Figure 12, the catheter 200 is placed into the popliteal vein "P" in the patient's leg "G"
and advanced to a region adjacent the leaflets "T" to deploy the vascular device upstream of the leaflets.
The delivery catheter is thus delivered in an antegrade fashion, with the tip extending downstream of leaflets "T" to deploy the device just upstream (defined in reference to the direction of blood flow) of the leaflets.
In the approach of Figure 13, the catheter 210 is inserted through the right jugular vein "'J", where it will be advanced through the superior and inferior vena cava, past the iliac vein "I", through the femoral vein "F" and into the popliteal vein "P"
through leaflets "L" in a retrograde fashion, i.e. opposite the direction of blood flow. The delivery catheter 210 would thus extend through the leaflet region just upstream of the leaflets. In Figure 14, the catheter 220 is placed in the right femoral vein "F", where it will be advanced in a retrograde manner to the popliteal vein "P" in the manner described above with respect to Figure 13.
In the contralateral approach of Figure 15, the catheter 230 is inserted through the left femoral vein "H" where it will be advanced around the iliac vein "I" and through the left femoral vein "F" into the popliteal vein "P."
Each of the delivery catheters 200, 210, 220 and 230 has respective ttibing 202, 212, 222 and 232, with a stopcock 204, 214, 224 and 234 to control saline infusion through the catheter to maintain the vascular device 10 (or device 100) in the cooled martensitic collapsed configuration for delivery. Inflation port 206, 216, 226 and 236 provides for fluid inftision to inflate the balloon which is mounted on the catheter shaft and positioned within the device 10. The otiter sheath of the delivery catheter slides with respect to the catheter shaft to expose the vascular device. Guidewire port 208, 218, 228 and 238 enables insertion of a conventional guidewire (not shown) to guide the delivery catheter intravascularly to the target site. A conventional access or introducer sheath (not shown) would be inserted through the skin and into the access vessel, and the respective delivery catheter would be inserted into the access vessel through the introducer sheath.
Figures 16-20 illustrate the method steps of insertion of the vascular device 10 in an antegrade fashion intravascularly in the popliteal vein "P". Catheter or delivery sheath' 200 is inserted over a conventional guidewire (not shown) so the distal tip 201 of the catheter shaft extends past, i.e. downstream of the valve leaflets L extending annularly from vessel wall "V" as shown in Figure 16. As can be appreciated, since there is a gap "a" between the valve leaflets "L", the valve cannot fiinction properly because the leaflets cannot properly close to prevent backflow. Also, due to the malfunctioning of the valve, the vessel wall becomes dilated as shown as the weight and pressure of the backflow blood pushes out the vessel wall.

Once the position of the sheath 200 is confirmed by venography, intravascular ultrasound, or other means, the sheath 205 is withdrawn with respect to catheter tip 201 in the direction of the arrow of Figure 17, exposing the vascular device 10.
When the sheath 205 has been fully withdrawn to expose the device 10, the device is warmed by the body temperature and transitions to its austenitic phase and the first memorized expanded configuration of Figure 18.

Next, a balloon member 240 on catheter shaft 209 which is positioned within device 10 is inflated via introduction of fluid through inflation lumen 206 (Figure 12) to fitrther expand the device 10 to a second expanded configuration shown in Figure 19.
That is, the device is expanded to a larger diameter than the diameter in its memorized configuration of Figure 18 so that vessel engaging members 28, 40 and 42 will engage the vessel wall "V" with the sharp tips and barbs penetrating the vessel wall to firmly grasp and secure it. This securement restricts both radial and axial movement of the vessel to enhance retention by the device 10.
After retention of the vessel wall as in Figure 19, the balloon is deflated (and the catheter 200 removed), resulting in the device 10 contracting from the second expanded configuration towards its memorized configuration. Preferably, the device 10 will return to substantially the same diameter as the first (memorized) expanded configuration. As contracted, the device 10, due to the engagement of the vessel engaging members with the internal wall of the vessel, pulls the vessel wall radially inwardly, thereby pulling the leaflets radially inwardly to the position of Figure 20 to close gap "a". As can be appreciated, the vessel wall is no longer dilated and the valve leaflets are sufficiently approximated such that their tips contact to block backflow and their function is therefore restored. The device 10 remains inside the vessel, maintaining the approximation of the vessel wall to maintain the proper functioning of the leaflets.
The changing diameters of the vascular device 10 can also be appreciated by reference to the transverse cross-sectional views of Figure 21A-21C. The delivery device has been removed for clarity. More specifically, Figure 21A corresponds to the initial position of the vascular device 10 in Figure 18 wherein the device 10 has been delivered to the target vessel, and has expanded to the first expanded (memorized) configuration but the vessel engaging members have not penetrated the vessel wall. It should be appreciated that in this configuration the vessel engaging members may or may not be in contact with the vessel wall, but in either case, do not fully penetrate and secure the vessel to the same extent as in the second position. As shown, by way of example, the unhealthy dilated vessel can have an internal diameter D l of approximately 14mm.
The balloon is not shown in Figure 21A for clarity.
Figure 21B corresponds to the position of the vascular device in Figure 19 wherein the balloon has been inflated to radially expand the device 10 to a second expanded position to enable the vessel engaging members to penetrate and retain (secure) the vessel wall. In this configuration, the vessel wall is further expanded to a diameter D2 of about 16mm, as the device is expanded to a diameter of about 16mm, with the hooks extending an additional 2mm so the device is expanded to 20mm.
Figure 21 C corresponds to the position of the vascular device 10 in Figure 20 wherein the balloon has been deflated and the device contracted to bring the vessel wall radially inwardly. The internal vessel wall diameter will preferably be about 12mm to close the gap between the leaflets. The diameter of the vascular device 10 preferably returns to the same diameter as in Figure 21A, e.g. about 12mm. As can be seen the device 10 abuts the vessel wall V.
Figures 22-26 illustrate retrograde insertion of the vascular device 10. In this approach the delivery catheter, e.g. catheter 210, is insei-ted in a direction against the blood flow so tip 211 extends past the valve leaflets "L" in the popliteal vein "P" and the catheter 210 is positioned so the device 10 will be deployed upstream of the leaflets.
The deployment of the device 10 is otherwise the same as in Figures 16-20.
That is, sheath 215 of the delivery device 210 is retracted in the direction of the arrow of Figure 23, to expose the device 10. Full retraction and removal of the sheath 215 to expose the device to the warmer body temperature enables it to expand to its memorized (first expanded) configuration of Figure 24. Subsequent expansion of balloon 250 (Figure 25) causes the vessel engaging members 42, 28, 40 to penetrate and retain the vessel wall so that upon deflation of the balloon, the device 10 returns to the memorized configuration of Figure 26 pulling the vessel wall inwardly and bringing the valve leaflets "L" closer together into apposition so the tips can contact. The changing diameters would also correspond to the aforedescribed transverse cross-sections of Figure 21 A-2 l C.
As can be appreciated, device 10 and device 100 are each symmetrical so that the "proximal" and "distal" portions are identified herein for convenience.
Figures 27-29 illustrate an alternate embodiment of the vascular device designated generally by reference numeral 300. Device 300 is placed within vessel V, e.g. the popliteal vein, to approximate leaflets "L" which as shown in Figure 27 are not functioning properly because the tips L 1 are spaced apart. In its first expanded configuration corresponding to its memorized shape of Figure 27, hooks 314 have not penetrated the vessel wall. The device 300 is formed by struts 302 as described in detail in the ' 120 application. Hooks 314, affixed to struts 302 at region 304 are crescent shaped and have pointed ends 306 with barbed portions 308.
In the expanded configuration of Figure 28, balloon 322 on shaft 324 of the delivery device has expanded the device 300 so that hooks 314 penetrate and securely engage the vessel wall "V"". The balloon would then be deflated and the device would return to its first expanded configuration bringing the vessel walls radially inwardly and bringing the valve leaflets into apposition in the same manner as described above with respect to vascular device 10.
Figures 30 and 31 illustrate an alternate method of placement of the vascular device. In this method, the vascular device 10 (or vascular device 100) is placed downstream (with respect to the direction of blood flow) of the valve leaflets. The delivery catheter 210' is inserted in the same antegrade manner as described above with respect to Figure 16, except it is advanced sufficiently past the valve leaflets L to enable downstream delivery of the device 10. Once positioned as shown in Figure 3 l, the sheath, 215' is withdrawn in the direction of the arrow, enabling the device 10 to expand to its memorized configuration. Vascular device 10 would then be further expanded by a balloon and then enabled to contract to its memorized configuration in the same manner as in Figures 18-20, the only difference being that the device 10 would grasp the vessel wall downstream of the valve leaflets to pull the vessel wall radially inwardly to bring the leaflets into apposition.
It should be appreciated that the device 10 or device 100 could also be delivered in a retrograde fashion such as shown in Figures 13-15 for positioning of the device downstream of the leaflets L.
Figures 32-34 illustrate an alternative delivery system and method for vascular device 10 (or device 100 which can be delivered in the same manner). In this method, exposure of the vascular device to body temperature and expansion of the balloon occur substantially simtiltaneously. To facilitate placement, a restraint system for connecting the vascular device to the balloon is provided.
More specifically, balloon 250' has a pair of sutures 252 attached thereto at a proximal and distal portion which wrap around the vascular device 10 forming a loop of suture to connect the balloon and the device. Although two sutures, are shown, it is contemplated that one suture or more than two sutures can be utilized to connect the balloon 250' to the vascular device 10. Additionally, other restraint systems such as perforated strips can be utilized.
In the position of Figure 32, the sutures (only one of which is shown, the other suture still within the sheath 215') are loosely wrapped arotind the device.
As the sheath 215' is retracted in the direction of the arrow, the balloon is inflated.
Thus, as the sheath 215' is ftilly withdrawn, the device expands to the position of Figure 33, without the intermediate step required in the methods described above, i.e. without the step of Figure 24 which first allows the device to expand to the memorized configuration. As the balloon expands, the pressure against the stitures 252 breaks the suture loops, thereby releasing them from the vascular device 10. This way, when the balloon 250' is deflated and withdrawn with the delivery catheter 210' from the body, the sutures 252 are removed as well. Upon deflation, the vascular device 10 returns to its memorized configuration to pull the vessel wall radially inwardly in the manner described above to assume a position like that of Figure 26.

Note that it is also contemplated that the balloon 250' can be inflated first within the sheath, followed by withdrawal of the sheath to expose the vascular device 10 to body temperature.

Additionally, the restraint system can also be utilized with the sequential method of deployment of Figures 16-20 and Figures 22-26. The restraint system, e.g.
the sutures, would help prevent axial movement and help center the balloon with respect to the vascular device 10.

While the above description contains many specifics, those specifics should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of preferred embodiments thereof. For example, instead of a balloon to expand the device to its second expanded diameter/condition, a mechanical means such as an expandable wire frame can be utilized. Also, instead of moving the sheath to expose the vascular device, the catheter can be advanced with respect to the sheath or both the catheter and sheath can move relative to each other in opposite directions.
Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.

Claims (25)

1. A vascular device comprising a proximal portion, an intermediate portion, a distal portion, and a plurality of vessel engaging members, the device movable from a collapsed insertion position having a first diameter to a second expanded position having a second diameter larger than the first diameter, the plurality of vessel engaging members extending outwardly from the device for securely engaging the internal wall of a vessel upon expansion of the device to the second expanded position, the vessel engaging members pulling the internal wall of the vessel radially inwardly upon movement of the device from the second expanded position toward a first expanded position having a third diameter, the third diameter being greater than the first diameter and less than the second diameter.
2. The vascular device of claim 1, wherein the device is composed of shape memory material and the first expanded position substantially corresponds to a memorized position of the device.
3. The vascular device of claim 1, wherein the device is composed of shape memory material and is initially movable from the collapsed position to the first expanded position in response to exposure to body temperature, and is subsequently moved from the first expanded position to the second expanded position by an expandable member.
4. The vascular device of claim 1, wherein the device is composed of shape memory material and is movable from the collapsed position to the second expanded position by the substantial simultaneous exposure to body temperature and expansion by an expandable member.
5. The vascular device of claim 2, wherein the device returns to the memorized position in response to exposure to body temperature.
6. The vascular device of any one of claims 1 to 5, wherein the device is expanded to the second expanded position by mechanical means positioned within the device.
7. The vascular device of any one of claims 1 to 5, wherein the device is moved to the second expanded position by expansion of a balloon positioned within the device.
8. The vascular device of any one of claims 1 to 7, wherein the vessel engaging members have sharp ends and extend from the distal portion and from the proximal portion of the device.
9. The vascular device of claim 8, wherein each of the vessel engaging members includes a barb, the sharp ends limiting axial movement of the vessel wall and the barb limiting radial movement of the vessel wall to enhance retention of the vessel.
10. The vascular device of claim 1, wherein in the collapsed position the intermediate portion includes a plurality of longitudinal strips with a gap between adjacent strips, the vessel engaging members being formed by respective cuts in the longitudinal strips, the longitudinal strips buckling radially outwardly upon expansion of the device.
11. The vascular device of any one of claims 1 to 7, wherein the vessel engaging members extend from the proximal portion and the distal portion and include hooks, the hooks extending substantially parallel to a longitudinal axis of the device in the collapsed position and substantially perpendicular to the longitudinal axis in the expanded position.
12. The vascular device of any one of claims 1 to 7, wherein the device includes a plurality of longitudinal strips, each of the longitudinal strips terminating at opposing ends in one of the vessel engaging members.
13. The vascular device of claim 12, further comprising a substantially straight slot formed in each of the longitudinal strips in the collapsed position of the device, each slot transforming to a substantially diamond shape when the device is moved to the first expanded position.
14. The vascular device of claim 13, wherein each of the vessel engaging members includes a sharp penetrating tip and a barb.
15. The vascular device of claim 14, wherein the longitudinal strips are connected by transverse ribs, the ribs being in substantial axial alignment.
16. The vascular device according to claim 1, wherein said device is a tubular-like member, and said plurality of vessel engaging members have penetrating tips extending from the proximal, distal and intermediate portions, wherein expansion of the tubular member to the expanded configuration causes the distal and proximal portions to move axially inwardly and the intermediate portion to buckle radially outwardly to enable the vessel engaging members to secure the vessel walls.
17. The vascular device according to claim 1, comprising a plurality of longitudinal strips, adjacent longitudinal strips formed by connecting ribs, each of the longitudinal strips terminating at opposing ends in one of the plurality of vessel engaging members to engage the vessel wall.
18. The vascular device of claim 17, further comprising a longitudinal slot formed in each of the longitudinal strips, the longitudinal slot forming a diamond shaped slot in the second expanded position of the device.
19. The vascular device of claim 18, wherein the longitudinal slots are in substantial axial alignment.
20. The vascular device of claim 19, wherein the connecting ribs are in substantial axial alignment.
21. A vascular system comprising:
a balloon catheter having an elongated shaft and an expandable balloon;
a vascular device mounted over the expandable balloon and composed of shape memory material and having a collapsed position and a memorized position, the vascular device expandable to an expanded position to engage the vessel walls and returnable substantially to the memorized position to bring the walls radially inwardly.
22. The vascular system of claim 21, wherein the vascular device is expandable first to the memorized condition in response to exposure to body temperature and subsequently expanded to the expanded position by inflation of the balloon.
23. The vascular system of claim 21, wherein the vascular device is expandable to the expanded position as the device is substantially simultaneously exposed to body temperature and the balloon is inflated.
24. The vascular system of claim 23, wherein the vascular device is connected to the balloon.
25. The vascular system of claim 24, further comprising a pair of looped sutures connecting the vascular device to the balloon, the sutures separable from the vascular device upon expansion of the balloon to a predetermined size.
CA002413248A 2000-06-26 2001-06-14 Vascular device for valve leaflet apposition Expired - Fee Related CA2413248C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21412000P 2000-06-26 2000-06-26
US60/214,120 2000-06-26
US09/877,639 US6695878B2 (en) 2000-06-26 2001-06-08 Vascular device for valve leaflet apposition
US09/877,639 2001-06-08
PCT/US2001/019374 WO2002003893A2 (en) 2000-06-26 2001-06-14 Vascular device for valve leaflet apposition

Publications (2)

Publication Number Publication Date
CA2413248A1 CA2413248A1 (en) 2002-01-17
CA2413248C true CA2413248C (en) 2009-04-14

Family

ID=26908698

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002413248A Expired - Fee Related CA2413248C (en) 2000-06-26 2001-06-14 Vascular device for valve leaflet apposition

Country Status (8)

Country Link
US (2) US6695878B2 (en)
EP (1) EP1294318B1 (en)
JP (1) JP4624641B2 (en)
AU (2) AU6987501A (en)
CA (1) CA2413248C (en)
DE (1) DE60107681T2 (en)
ES (2) ES2407136T3 (en)
WO (1) WO2002003893A2 (en)

Families Citing this family (332)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006134A (en) * 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
US20030130657A1 (en) * 1999-08-05 2003-07-10 Tom Curtis P. Devices for applying energy to tissue
US7175644B2 (en) * 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US20040073155A1 (en) * 2000-01-14 2004-04-15 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in tissue
US20050137715A1 (en) * 1999-08-05 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
WO2001010314A2 (en) * 1999-08-05 2001-02-15 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US20050060044A1 (en) * 1999-08-05 2005-03-17 Ed Roschak Methods and devices for maintaining patency of surgically created channels in a body organ
US7422563B2 (en) * 1999-08-05 2008-09-09 Broncus Technologies, Inc. Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow
US6440164B1 (en) * 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US8016877B2 (en) * 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US6458153B1 (en) * 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
EP1401358B1 (en) * 2000-06-30 2016-08-17 Medtronic, Inc. Apparatus for performing a procedure on a cardiac valve
AU2001273088A1 (en) * 2000-06-30 2002-01-30 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US6932838B2 (en) * 2000-09-29 2005-08-23 Tricardia, Llc Venous valvuloplasty device and method
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US20040093075A1 (en) * 2000-12-15 2004-05-13 Titus Kuehne Stent with valve and method of use thereof
US7087088B2 (en) * 2001-05-24 2006-08-08 Torax Medical, Inc. Methods and apparatus for regulating the flow of matter through body tubing
US8282668B2 (en) * 2001-06-18 2012-10-09 Rex Medical, L.P. Vein filter
US7179275B2 (en) * 2001-06-18 2007-02-20 Rex Medical, L.P. Vein filter
US8771302B2 (en) * 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
FR2826863B1 (en) * 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
FR2828263B1 (en) * 2001-08-03 2007-05-11 Philipp Bonhoeffer DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE
US6726716B2 (en) * 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US20050137611A1 (en) * 2001-09-04 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US20050060042A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US7097659B2 (en) * 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
AU2002359554A1 (en) * 2001-12-03 2003-06-17 Intek Technology L.L.C. Temporary, repositionable or retrievable intraluminal devices
US20040111147A1 (en) 2002-12-03 2004-06-10 Rabkin Dmitry J. Temporary, repositionable or retrievable intraluminal devices
US20030144578A1 (en) * 2002-01-25 2003-07-31 Koster J. Kenneth Anastomosis anchoring device and method
WO2008051294A2 (en) * 2006-05-02 2008-05-02 C. R. Bard, Inc. Ivc filter with translating hooks
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US7331992B2 (en) * 2002-02-20 2008-02-19 Bard Peripheral Vascular, Inc. Anchoring device for an endoluminal prosthesis
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
EP2353557B1 (en) * 2002-03-20 2020-05-27 Spiration, Inc. Removable anchored lung volume reduction devices
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US6752828B2 (en) * 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7007698B2 (en) * 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
CA2482935A1 (en) * 2002-04-19 2003-10-30 Broncus Technologies, Inc. Devices for maintaining surgically created openings
US6960233B1 (en) * 2002-12-10 2005-11-01 Torax Medical, Inc. Methods and apparatus for improving the function of biological passages
US7695427B2 (en) 2002-04-26 2010-04-13 Torax Medical, Inc. Methods and apparatus for treating body tissue sphincters and the like
US20050197715A1 (en) * 2002-04-26 2005-09-08 Torax Medical, Inc. Methods and apparatus for implanting devices into non-sterile body lumens or organs
US8641727B2 (en) 2002-06-13 2014-02-04 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060241656A1 (en) * 2002-06-13 2006-10-26 Starksen Niel F Delivery devices and methods for heart valve repair
DE10362367B3 (en) * 2002-08-13 2022-02-24 Jenavalve Technology Inc. Device for anchoring and aligning prosthetic heart valves
CO5500017A1 (en) * 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
CA2502967A1 (en) * 2002-10-24 2004-05-06 Boston Scientific Limited Venous valve apparatus and method
US6945957B2 (en) * 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US7393339B2 (en) * 2003-02-21 2008-07-01 C. R. Bard, Inc. Multi-lumen catheter with separate distal tips
EP1605866B1 (en) * 2003-03-03 2016-07-06 Syntach AG Electrical conduction block implant device
US20050049675A1 (en) * 2003-03-28 2005-03-03 Board Of Regents, The University Of Texas System Medical devices and related methods
US7100616B2 (en) 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
EP1613373A4 (en) * 2003-04-08 2008-09-10 Univ Leland Stanford Junior Implantable arteriovenous shunt device
US7967769B2 (en) * 2003-04-08 2011-06-28 Rox Medical Inc. Implantable arterio-venous shunt devices and methods for their use
US7380163B2 (en) * 2003-04-23 2008-05-27 Dot Hill Systems Corporation Apparatus and method for deterministically performing active-active failover of redundant servers in response to a heartbeat link failure
EP1648340B1 (en) * 2003-05-19 2010-03-03 SeptRx, Inc. Tissue distention device and related methods for therapeutic intervention
WO2004103223A1 (en) * 2003-05-20 2004-12-02 The Cleveland Clinic Foundation Apparatus and methods for repair of a cardiac valve
US20040260394A1 (en) * 2003-06-20 2004-12-23 Medtronic Vascular, Inc. Cardiac valve annulus compressor system
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
CA2538329A1 (en) 2003-09-15 2005-03-31 Abbott Laboratories Suture locking device and methods
US8394114B2 (en) * 2003-09-26 2013-03-12 Medtronic, Inc. Surgical connection apparatus and methods
US9579194B2 (en) * 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
SE526861C2 (en) 2003-11-17 2005-11-15 Syntach Ag Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7854761B2 (en) * 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7704266B2 (en) 2004-01-22 2010-04-27 Rex Medical, L.P. Vein filter
US8500774B2 (en) 2004-01-22 2013-08-06 Rex Medical, L.P. Vein filter
US8062326B2 (en) 2004-01-22 2011-11-22 Rex Medical, L.P. Vein filter
US8162972B2 (en) 2004-01-22 2012-04-24 Rex Medical, Lp Vein filter
US7338512B2 (en) * 2004-01-22 2008-03-04 Rex Medical, L.P. Vein filter
US9510929B2 (en) 2004-01-22 2016-12-06 Argon Medical Devices, Inc. Vein filter
US8211140B2 (en) * 2004-01-22 2012-07-03 Rex Medical, L.P. Vein filter
US7976562B2 (en) 2004-01-22 2011-07-12 Rex Medical, L.P. Method of removing a vein filter
US9398967B2 (en) * 2004-03-02 2016-07-26 Syntach Ag Electrical conduction block implant device
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
US8979922B2 (en) 2004-03-11 2015-03-17 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
US7942927B2 (en) 2004-03-15 2011-05-17 Baker Medical Research Institute Treating valve failure
WO2005096988A1 (en) * 2004-04-01 2005-10-20 Cook Incorporated A device for retracting the walls of a body vessel with remodelable material
EP1737390A1 (en) * 2004-04-08 2007-01-03 Cook Incorporated Implantable medical device with optimized shape
US8425539B2 (en) 2004-04-12 2013-04-23 Xlumena, Inc. Luminal structure anchoring devices and methods
US7625390B2 (en) * 2004-04-16 2009-12-01 Cook Incorporated Removable vena cava filter
WO2005102213A1 (en) * 2004-04-16 2005-11-03 Cook, Inc. Removable vena cava filter having primary struts for enhanced retrieval and delivery
US7972353B2 (en) * 2004-04-16 2011-07-05 Cook Medical Technologies Llc Removable vena cava filter with anchoring feature for reduced trauma
JP4918637B2 (en) * 2004-04-16 2012-04-18 クック メディカル テクノロジーズ エルエルシー Retrievable vena cava filter with anchor hooks positioned inward in a folded configuration
EP1737382B1 (en) * 2004-04-16 2011-03-30 Cook Incorporated Removable vena cava filter for reduced trauma in collapsed configuration
EP1753374A4 (en) 2004-04-23 2010-02-10 3F Therapeutics Inc Implantable prosthetic valve
EP1765451B1 (en) 2004-06-14 2021-11-17 Edwards Lifesciences Corporation Devices for arterio-venous fistula creation
US8162963B2 (en) * 2004-06-17 2012-04-24 Maquet Cardiovascular Llc Angled anastomosis device, tools and method of using
US20080288060A1 (en) * 2004-07-06 2008-11-20 Baker Medical Research Institute Treating Valvular Insufficiency
CA2591543A1 (en) * 2004-07-19 2006-02-09 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US7704267B2 (en) 2004-08-04 2010-04-27 C. R. Bard, Inc. Non-entangling vena cava filter
US7828814B2 (en) 2004-08-27 2010-11-09 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060047337A1 (en) 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US9706997B2 (en) 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US11207457B2 (en) * 2004-08-27 2021-12-28 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US20060052867A1 (en) * 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
EP1802252B1 (en) * 2004-09-27 2011-07-20 Cook, Inc. Removable vena cava filter
CA2580124C (en) * 2004-09-27 2014-05-13 Rex Medical, L.P. Vein filter
US7905826B2 (en) * 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
US8562672B2 (en) * 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
WO2006054107A2 (en) * 2004-11-19 2006-05-26 Medtronic Inc. Method and apparatus for treatment of cardiac valves
US20060111704A1 (en) * 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
WO2006062976A2 (en) * 2004-12-07 2006-06-15 Cook Incorporated Methods for modifying vascular vessel walls
US8226592B2 (en) 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
DE102005003632A1 (en) * 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060173490A1 (en) * 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) * 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7878966B2 (en) * 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7670368B2 (en) * 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7780722B2 (en) * 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
ITTO20050074A1 (en) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
US7867274B2 (en) * 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7722666B2 (en) * 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
WO2006113906A1 (en) * 2005-04-20 2006-10-26 The Cleveland Clinic Foundation Apparatus and method for replacing a cardiac valve
US20060253190A1 (en) * 2005-05-06 2006-11-09 Kuo Michael D Removeable stents
MX2007013932A (en) 2005-05-12 2008-01-28 Bard Inc C R Removable embolus blood clot filter.
US8613754B2 (en) 2005-05-12 2013-12-24 C. R. Bard, Inc. Tubular filter
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
WO2006130873A2 (en) * 2005-06-01 2006-12-07 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
EP1906873A2 (en) * 2005-07-27 2008-04-09 Georgia Tech Research Corporation Implantable prosthetic vascular valve
CA2616818C (en) 2005-08-09 2014-08-05 C.R. Bard, Inc. Embolus blood clot filter and delivery system
US7569071B2 (en) * 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
AU2006315812B2 (en) 2005-11-10 2013-03-28 Cardiaq Valve Technologies, Inc. Balloon-expandable, self-expanding, vascular prosthesis connecting stent
US20070112423A1 (en) * 2005-11-16 2007-05-17 Chu Jack F Devices and methods for treatment of venous valve insufficiency
MX344147B (en) 2005-11-18 2016-12-07 Bard Inc C R Vena cava filter with filament.
US20070123994A1 (en) * 2005-11-29 2007-05-31 Ethicon Endo-Surgery, Inc. Internally Placed Gastric Restriction Device
US7799038B2 (en) * 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US20070239271A1 (en) * 2006-04-10 2007-10-11 Than Nguyen Systems and methods for loading a prosthesis onto a minimally invasive delivery system
US7442207B2 (en) * 2006-04-21 2008-10-28 Medtronic Vascular, Inc. Device, system, and method for treating cardiac valve regurgitation
US8551161B2 (en) 2006-04-25 2013-10-08 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
US10188496B2 (en) 2006-05-02 2019-01-29 C. R. Bard, Inc. Vena cava filter formed from a sheet
DE102006025253A1 (en) * 2006-05-22 2007-11-29 Sommoggy und Erdödy, Stefan von, Prof. Dr. med. Stent, for interventional applications, in particular for varicosis treatment and for the treatment of chronic venous insufficiency (CVI)
CA2655158A1 (en) 2006-06-05 2007-12-13 C.R. Bard Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
US20080126131A1 (en) * 2006-07-17 2008-05-29 Walgreen Co. Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen
US8298281B2 (en) * 2006-07-18 2012-10-30 Cordis Corporation Twisted anchoring barb for stent of abdominal aortic aneurysm (AAA) device
US10076401B2 (en) 2006-08-29 2018-09-18 Argon Medical Devices, Inc. Vein filter
US7513224B2 (en) * 2006-09-11 2009-04-07 The Scuderi Group, Llc Split-cycle aircraft engine
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8348996B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies Ltd. Valve prosthesis implantation techniques
WO2008047354A2 (en) 2006-10-16 2008-04-24 Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
US20080161825A1 (en) * 2006-11-20 2008-07-03 Stout Medical Group, L.P. Anatomical measurement tool
JP2010510029A (en) * 2006-11-22 2010-04-02 ブロンカス テクノロジーズ, インコーポレイテッド Device for passage creation and blood vessel sensing
US8747459B2 (en) * 2006-12-06 2014-06-10 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
US20100121433A1 (en) * 2007-01-08 2010-05-13 Millipede Llc, A Corporation Of Michigan Reconfiguring heart features
WO2008091493A1 (en) 2007-01-08 2008-07-31 California Institute Of Technology In-situ formation of a valve
US20100249920A1 (en) * 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US9192471B2 (en) * 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20080177380A1 (en) * 2007-01-19 2008-07-24 Starksen Niel F Methods and devices for heart tissue repair
AU2008211193A1 (en) * 2007-01-29 2008-08-07 Cook Incorporated Medical prosthesis and method of production
WO2008097589A1 (en) 2007-02-05 2008-08-14 Boston Scientific Limited Percutaneous valve, system, and method
JP5604110B2 (en) * 2007-02-05 2014-10-08 ボストン サイエンティフィック リミテッド System for delivering a valve
CA2677633C (en) * 2007-02-15 2015-09-08 Medtronic, Inc. Multi-layered stents and methods of implanting
EP2129333B1 (en) * 2007-02-16 2019-04-03 Medtronic, Inc Replacement prosthetic heart valves
US8070802B2 (en) * 2007-02-23 2011-12-06 The Trustees Of The University Of Pennsylvania Mitral valve system
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
FR2915087B1 (en) 2007-04-20 2021-11-26 Corevalve Inc IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.
US8828079B2 (en) * 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
US8292907B2 (en) * 2007-08-31 2012-10-23 Cook Medical Technologies Llc Balloon assisted occlusion device
US20090062839A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Barbed stent vascular occlusion device
US8834551B2 (en) * 2007-08-31 2014-09-16 Rex Medical, L.P. Vascular device with valve for approximating vessel wall
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
EP2211779B1 (en) 2007-10-15 2014-08-20 Edwards Lifesciences Corporation Transcatheter heart valve with micro-anchors
WO2009067432A1 (en) * 2007-11-19 2009-05-28 Cook Incorporated Valve frame
US7846199B2 (en) * 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
US7892276B2 (en) * 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8246672B2 (en) * 2007-12-27 2012-08-21 Cook Medical Technologies Llc Endovascular graft with separately positionable and removable frame units
US20090171456A1 (en) * 2007-12-28 2009-07-02 Kveen Graig L Percutaneous heart valve, system, and method
US9149358B2 (en) * 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
EP2254513B1 (en) * 2008-01-24 2015-10-28 Medtronic, Inc. Stents for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
JP5687070B2 (en) * 2008-01-24 2015-03-18 メドトロニック,インコーポレイテッド Stent for prosthetic heart valve
US20090287290A1 (en) * 2008-01-24 2009-11-19 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
EP2254512B1 (en) * 2008-01-24 2016-01-06 Medtronic, Inc. Markers for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
EP3005984A1 (en) 2008-02-28 2016-04-13 Medtronic Inc. Prosthetic heart valve systems
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8696743B2 (en) * 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
ATE554731T1 (en) 2008-05-16 2012-05-15 Sorin Biomedica Cardio Srl ATRAAUMATIC PROSTHETIC HEART VALVE PROSTHESIS
US8696739B2 (en) * 2008-08-29 2014-04-15 Cook Medical Technologies Llc Barbed anchor
EP4018967A1 (en) 2008-09-15 2022-06-29 Medtronic Ventor Technologies Ltd Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
WO2010033725A2 (en) * 2008-09-20 2010-03-25 Steven Craig Anderson Apparatus and method for tissue adhesion
US9138233B2 (en) * 2011-03-17 2015-09-22 Micokoll Inc. Apparatus and method for tissue adhesion
AU2009295960A1 (en) * 2008-09-29 2010-04-01 Cardiaq Valve Technologies, Inc. Heart valve
WO2010039862A1 (en) * 2008-09-30 2010-04-08 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
EP2341871B1 (en) 2008-10-01 2017-03-22 Edwards Lifesciences CardiAQ LLC Delivery system for vascular implant
US8137398B2 (en) * 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
DE102008057213A1 (en) * 2008-11-06 2010-05-12 Aesculap Ag Medical device product, a surgical kit and a manufacturing process for the medical device product
US8246648B2 (en) * 2008-11-10 2012-08-21 Cook Medical Technologies Llc Removable vena cava filter with improved leg
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8052741B2 (en) * 2009-03-23 2011-11-08 Medtronic Vascular, Inc. Branch vessel prosthesis with a roll-up sealing assembly
AU2010236288A1 (en) 2009-04-15 2011-10-20 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
WO2010123668A1 (en) * 2009-04-20 2010-10-28 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
ES2523218T3 (en) 2009-04-27 2014-11-24 Sorin Group Italia S.R.L. Prosthetic vascular duct
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US8808369B2 (en) * 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US9226826B2 (en) * 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
WO2011130579A1 (en) * 2010-04-14 2011-10-20 Abbott Cardiovascular Systems Inc. Intraluminal scaffold and method of making and using same
CN101953725B (en) * 2010-04-19 2013-06-19 杭州启明医疗器械有限公司 Artificial valve displacement device and stent
CN101953723B (en) * 2010-04-19 2013-02-27 杭州启明医疗器械有限公司 Stably-positioned artificial cardiac valve replacement device and stent
US9326870B2 (en) 2010-04-23 2016-05-03 Medtronic Vascular, Inc. Biodegradable stent having non-biodegradable end portions and mechanisms for increased stent hoop strength
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
CA2803149C (en) 2010-06-21 2018-08-14 Impala, Inc. Replacement heart valve
US20120053680A1 (en) * 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
AU2011295854B2 (en) * 2010-09-01 2016-07-21 Mvalve Technologies Ltd. Cardiac valve support structure
CN103118629A (en) 2010-09-01 2013-05-22 美敦力瓦斯科尔勒戈尔韦有限公司 Prosthetic valve support structure
EP2618784B1 (en) 2010-09-23 2016-05-25 Edwards Lifesciences CardiAQ LLC Replacement heart valves and delivery devices
US8603137B2 (en) 2010-11-01 2013-12-10 Abbott Cardiovascular Systems, Inc. Methods and systems for establishing hemostasis relative to a puncture
US9271733B2 (en) 2010-11-11 2016-03-01 Willson T. Asfora Sutureless vascular anastomosis connection
US9345484B2 (en) 2010-11-11 2016-05-24 Asfora Ip, Llc Deployment tool for sutureless vascular anastomosis connection
EP2640280B1 (en) 2010-11-16 2022-03-16 TVA Medical, Inc. Devices for forming a fistula
US10022212B2 (en) 2011-01-13 2018-07-17 Cook Medical Technologies Llc Temporary venous filter with anti-coagulant delivery method
US8685047B2 (en) * 2011-02-07 2014-04-01 Abbott Vascular, Inc. Scaffold device for preventing tissue trauma
EP2486894B1 (en) 2011-02-14 2021-06-09 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
EP2486893B1 (en) 2011-02-14 2017-07-05 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
US9149265B2 (en) 2011-02-26 2015-10-06 Abbott Cardiovascular Systems, Inc. Hinged tissue support device
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
JP2014521381A (en) 2011-05-13 2014-08-28 ブロンカス テクノロジーズ, インコーポレイテッド Methods and devices for tissue ablation
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9289282B2 (en) 2011-05-31 2016-03-22 Edwards Lifesciences Corporation System and method for treating valve insufficiency or vessel dilatation
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9055932B2 (en) 2011-08-26 2015-06-16 Abbott Cardiovascular Systems, Inc. Suture fastener combination device
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
EP2609893B1 (en) 2011-12-29 2014-09-03 Sorin Group Italia S.r.l. A kit for implanting prosthetic vascular conduits
US9138214B2 (en) 2012-03-02 2015-09-22 Abbott Cardiovascular Systems, Inc. Suture securing systems, devices and methods
US9168122B2 (en) 2012-04-26 2015-10-27 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US9486276B2 (en) 2012-10-11 2016-11-08 Tva Medical, Inc. Devices and methods for fistula formation
US9486132B2 (en) * 2013-01-17 2016-11-08 Abbott Cardiovascular Systems, Inc. Access device for accessing tissue
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
EP3566740A1 (en) 2013-03-14 2019-11-13 TVA Medical, Inc. Fistula formulation/formation devices
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
JP6561044B2 (en) 2013-05-03 2019-08-14 メドトロニック,インコーポレイテッド Valve transfer tool
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
FR3009185A1 (en) * 2013-08-01 2015-02-06 Cousin Biotech ANASTOMOTIC DEVICE FOR JOINING LUMENS OR VISCERES BETWEEN THEM
JP6563394B2 (en) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド Radially foldable frame for an artificial valve and method for manufacturing the frame
US9724121B2 (en) 2014-02-02 2017-08-08 TriReme Medical, LLC Apparatus and methods for recannalization, valve repair and replacement
CA2938614C (en) 2014-02-21 2024-01-23 Edwards Lifesciences Cardiaq Llc Delivery device for controlled deployement of a replacement valve
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US10695534B2 (en) 2014-03-14 2020-06-30 Tva Medical, Inc. Fistula formation devices and methods therefor
US9668861B2 (en) 2014-03-15 2017-06-06 Rex Medical, L.P. Vascular device for treating venous valve insufficiency
US20150328000A1 (en) 2014-05-19 2015-11-19 Cardiaq Valve Technologies, Inc. Replacement mitral valve with annular flap
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
WO2016033374A1 (en) 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
WO2016097337A1 (en) * 2014-12-19 2016-06-23 Transcatheter Technologies Gmbh Minimally invasive mitral valve replacement with brim
US10603040B1 (en) 2015-02-09 2020-03-31 Tva Medical, Inc. Methods for treating hypertension and reducing blood pressure with formation of fistula
CN107530166B (en) 2015-02-13 2020-01-31 魅尔皮德股份有限公司 Valve replacement using a rotating anchor
EP3284414A4 (en) * 2015-04-17 2018-12-19 Jichi Medical University Anastomosis connector
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
JP6767388B2 (en) 2015-05-01 2020-10-14 イェーナヴァルヴ テクノロジー インコーポレイテッド Devices and methods to reduce the proportion of pacemakers in heart valve replacement
WO2016209970A1 (en) 2015-06-22 2016-12-29 Edwards Lifescience Cardiaq Llc Actively controllable heart valve implant and methods of controlling same
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
WO2017062762A2 (en) 2015-10-07 2017-04-13 Sigmon John C Methods, medical devices and kits for modifying the luminal profile of a body vessel
JP6892446B2 (en) 2015-11-17 2021-06-23 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Implantable equipment and delivery system to reshape the heart valve annulus
US10492885B2 (en) * 2015-12-17 2019-12-03 Ethicon Llc Ultrasonic surgical instrument with cleaning port
US10874422B2 (en) 2016-01-15 2020-12-29 Tva Medical, Inc. Systems and methods for increasing blood flow
JP6894440B2 (en) 2016-01-15 2021-06-30 ティーブイエー メディカル, インコーポレイテッド Devices and methods for forming fistulas
AU2017207507B2 (en) 2016-01-15 2021-11-11 Tva Medical, Inc. Devices and methods for advancing a wire
EP3407835A4 (en) 2016-01-29 2019-06-26 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
US10321984B2 (en) * 2016-02-19 2019-06-18 Cook Medical Technologies Llc Spiral flow inducing stent and canula cut method of making same
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US20200146854A1 (en) 2016-05-16 2020-05-14 Elixir Medical Corporation Methods and devices for heart valve repair
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
CN109789017B (en) 2016-08-19 2022-05-31 爱德华兹生命科学公司 Steerable delivery system for replacing a mitral valve and methods of use
EP3503848B1 (en) 2016-08-26 2021-09-22 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
CA3037525A1 (en) 2016-09-25 2018-03-29 Tva Medical, Inc. Vascular stent devices and methods
US10758348B2 (en) 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
US10653510B2 (en) 2016-11-09 2020-05-19 Boston Scientific Scimed, Inc. Stent including displacement capabilities
FR3058631B1 (en) * 2016-11-14 2019-01-25 Laboratoires Invalv IMPLANT FOR TREATING A BIOLOGICAL VALVE
CA3042588A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
US10548731B2 (en) 2017-02-10 2020-02-04 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
WO2019010321A1 (en) 2017-07-06 2019-01-10 Edwards Lifesciences Corporation Steerable rail delivery system
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
WO2019147846A2 (en) 2018-01-25 2019-08-01 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
WO2019224577A1 (en) 2018-05-23 2019-11-28 Sorin Group Italia S.R.L. A cardiac valve prosthesis
EP3610822B1 (en) * 2018-08-14 2021-07-07 Endosmart Gesellschaft für Medizintechnik mbH Marking body and method for production of this marking body
WO2020093172A1 (en) 2018-11-08 2020-05-14 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
CA3135753C (en) 2019-04-01 2023-10-24 Neovasc Tiara Inc. Controllably deployable prosthetic valve
AU2020271896B2 (en) 2019-04-10 2022-10-13 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CN114025813A (en) 2019-05-20 2022-02-08 内奥瓦斯克迪亚拉公司 Introducer with hemostatic mechanism
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve
EP3998969A4 (en) 2019-07-15 2023-08-02 Ancora Heart, Inc. Devices and methods for tether cutting
US11439383B2 (en) 2019-08-20 2022-09-13 Abbott Cardiovascular Systems, Inc. Self locking suture and self locking suture mediated closure device
US11786355B2 (en) 2020-01-30 2023-10-17 Boston Scientific Scimed, Inc. Radial adjusting self-expanding stent with anti-migration features
EP3906962A1 (en) * 2020-05-07 2021-11-10 Gefässpraxis Dr. Erpen AG Device for closing the opening of a vein in the treatment of varicosis

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5669936A (en) * 1983-12-09 1997-09-23 Endovascular Technologies, Inc. Endovascular grafting system and method for use therewith
JP2579655B2 (en) 1986-07-17 1997-02-05 ヴァソ・プロダクツ・オーストラリア・プロプライエタリー・リミテッド Venous valve function repair cuff
CH678393A5 (en) * 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
DK0474748T3 (en) 1989-05-31 1995-05-01 Baxter Int Biological flap prosthesis
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
JP2539955B2 (en) * 1991-02-25 1996-10-02 テルモ株式会社 A catheter equipped with a device for securing the inner diameter of the lumen of a tubular organ
US5350398A (en) 1991-05-13 1994-09-27 Dusan Pavcnik Self-expanding filter for percutaneous insertion
US5397351A (en) 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
IT1247037B (en) 1991-06-25 1994-12-12 Sante Camilli ARTIFICIAL VENOUS VALVE
US5792155A (en) 1991-07-16 1998-08-11 Van Cleef; Jean-Francois Process for partially or totally flattening a vein
CA2127701C (en) 1992-01-27 1999-06-15 John T. M. Wright Annuloplasty and suture rings
CA2087132A1 (en) * 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
JPH07505316A (en) 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
WO1995014500A1 (en) 1992-05-01 1995-06-01 Beth Israel Hospital A stent
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5562725A (en) * 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
AU689094B2 (en) * 1993-04-22 1998-03-26 C.R. Bard Inc. Non-migrating vascular prosthesis and minimally invasive placement system therefor
JP4046760B2 (en) * 1994-05-19 2008-02-13 ボストン サイエンティフィック サイムド, インコーポレイテッド Improved tissue support device
US5397355A (en) * 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
AU3783195A (en) * 1994-11-15 1996-05-23 Advanced Cardiovascular Systems Inc. Intraluminal stent for attaching a graft
AU3783295A (en) * 1994-11-16 1996-05-23 Advanced Cardiovascular Systems Inc. Shape memory locking mechanism for intravascular stent
US5609598A (en) 1994-12-30 1997-03-11 Vnus Medical Technologies, Inc. Method and apparatus for minimally invasive treatment of chronic venous insufficiency
JP3507503B2 (en) * 1995-03-10 2004-03-15 インプラ・インコーポレーテッド Sealable stent for body cavity, method for producing the same, and method for introducing the same into body cavity
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
CA2171896C (en) 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US5643278A (en) * 1995-04-06 1997-07-01 Leocor, Inc. Stent delivery system
US5746766A (en) 1995-05-09 1998-05-05 Edoga; John K. Surgical stent
US5716399A (en) 1995-10-06 1998-02-10 Cardiomend Llc Methods of heart valve repair
US5593417A (en) 1995-11-27 1997-01-14 Rhodes; Valentine J. Intravascular stent with secure mounting means
US5885258A (en) 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US6036687A (en) 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
JP4060887B2 (en) 1996-03-05 2008-03-12 ヴィナス メディカル テクノロジーズ インコーポレイテッド Vascular catheter utilization system for heating tissue
US5830179A (en) 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US6149660A (en) 1996-04-22 2000-11-21 Vnus Medical Technologies, Inc. Method and apparatus for delivery of an appliance in a vessel
WO1997040755A1 (en) 1996-04-29 1997-11-06 W.L. Gore & Associates, Inc. Device for restoring competence to venous valves
EP0808614B1 (en) 1996-05-23 2003-02-26 Samsung Electronics Co., Ltd. Flexible self-expandable stent and method for making the same
US5855601A (en) 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6086610A (en) 1996-10-22 2000-07-11 Nitinol Devices & Components Composite self expanding stent device having a restraining element
JP4082736B2 (en) 1996-11-07 2008-04-30 セント ジュード メディカル エーティージー, インコーポレイテッド Medical graft connectors and fasteners
US6080160A (en) 1996-12-04 2000-06-27 Light Sciences Limited Partnership Use of shape memory alloy for internally fixing light emitting device at treatment site
EP0850607A1 (en) * 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US6425915B1 (en) * 1997-03-18 2002-07-30 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
ATE445366T1 (en) 1997-06-27 2009-10-15 Univ Columbia DEVICE FOR REPAIRING CIRCUIT VALVES
US6042606A (en) 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6014589A (en) 1997-11-12 2000-01-11 Vnus Medical Technologies, Inc. Catheter having expandable electrodes and adjustable stent
US6224626B1 (en) 1998-02-17 2001-05-01 Md3, Inc. Ultra-thin expandable stent
US6024096A (en) 1998-05-01 2000-02-15 Correstore Inc Anterior segment ventricular restoration apparatus and method
JP4399585B2 (en) 1998-06-02 2010-01-20 クック インコーポレイティド Multi-sided medical device
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6258118B1 (en) 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6336937B1 (en) * 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
DE19857887B4 (en) 1998-12-15 2005-05-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring support for a heart valve prosthesis
EP1161185A2 (en) * 1999-03-09 2001-12-12 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US6287339B1 (en) 1999-05-27 2001-09-11 Sulzer Carbomedics Inc. Sutureless heart valve prosthesis
US6136025A (en) 1999-07-27 2000-10-24 Barbut; Denise R. Endoscopic arterial pumps for treatment of cardiac insufficiency and venous pumps for right-sided cardiac support
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
AU4543201A (en) * 2000-03-03 2001-09-17 Patricia E Thorpe Bulbous valve and stent for treating vascular reflux
US6572646B1 (en) * 2000-06-02 2003-06-03 Advanced Cardiovascular Systems, Inc. Curved nitinol stent for extremely tortuous anatomy
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US6527800B1 (en) * 2000-06-26 2003-03-04 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US6503272B2 (en) 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves

Also Published As

Publication number Publication date
ES2407136T3 (en) 2013-06-11
US20040186561A1 (en) 2004-09-23
EP1294318B1 (en) 2004-12-08
ES2234852T3 (en) 2005-07-01
WO2002003893A2 (en) 2002-01-17
DE60107681T2 (en) 2005-12-01
US7041128B2 (en) 2006-05-09
WO2002003893A3 (en) 2002-06-27
JP4624641B2 (en) 2011-02-02
AU2001269875B2 (en) 2006-04-06
CA2413248A1 (en) 2002-01-17
JP2004514467A (en) 2004-05-20
AU6987501A (en) 2002-01-21
EP1294318A2 (en) 2003-03-26
DE60107681D1 (en) 2005-01-13
US20020002401A1 (en) 2002-01-03
US6695878B2 (en) 2004-02-24

Similar Documents

Publication Publication Date Title
CA2413248C (en) Vascular device for valve leaflet apposition
US6527800B1 (en) Vascular device and method for valve leaflet apposition
EP1512383B1 (en) A vascular system for valve leaflet apposition
US9675474B2 (en) Vascular device with valve for approximating vessel wall
CA2446596C (en) Vascular device with valve for approximating vessel wall
AU2001269875A1 (en) Vascular device for valve leaflet apposition
US10159488B2 (en) Vascular device and method for valve leaflet apposition
US8834551B2 (en) Vascular device with valve for approximating vessel wall
AU2002225770A1 (en) Vascular device with valve for approximating vessel wall

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160614

MKLA Lapsed

Effective date: 20160614